aminoglutethimide has been researched along with Immunologic Deficiency Syndromes in 1 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godfrey, DI | 1 |
| Purton, JF | 1 |
| Boyd, RL | 1 |
| Cole, TJ | 1 |
1 review available for aminoglutethimide and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Stress-free T-cell development: glucocorticoids are not obligatory.
Topics: Aminoglutethimide; Animals; Cell Differentiation; Clonal Deletion; DNA, Antisense; Glucocorticoids; | 2000 |